January 24, 2015

Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease

.   .   

This elegant double-blind, placebo-controlled trial shows the addition of an ARB in patients with ADPKD already on an ACE inhibitor did not alter the decline in estimated GFR.  Based on this evidence, there seems to be no role for dual RAAS blockade in this population.

Related Articles:

Chronic Kidney Disease, Polycystic Kidney Disease

Comments are closed.